Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
08/2002
08/01/2002WO2002059105A1 Styrene derivatives and process for production thereof
08/01/2002WO2002058631A2 Primary intermediates for oxidative coloration of hair
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020102672 Generating a purified solution of lactic acid; provide lactate solution, concentrate lactate, acidify, remove calcium sulfate, extract the acidulated solution, strip loaded solvent and recover lactic acid
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002CA2435801A1 Styrene derivative and process for preparing the same
08/01/2002CA2434311A1 4-amino-2-(1-aryloxy-ethyl)phenol compounds as primary intermediates for oxydative coloration of hair
07/2002
07/31/2002CN1088453C Fluorine-substituted liquid-crystal compound, liquid-crystal composition and liquid-crystal display device
07/30/2002US6426347 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
07/25/2002WO2002057251A2 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
07/25/2002US20020099056 Used for treatment of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders neuroleptic agents.
07/25/2002US20020099050 E.g., 1-(1,4-benzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine), 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine); and 1-(1,3-benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine
07/25/2002DE10158803A1 Production of difluoromethoxy-bridged compounds, involves addition of acid to ketene dithioketal, reaction of the carbenium salt with hydroxy compound and fluorodesulfurisation of the dithio-ortho-ester
07/25/2002CA2435371A1 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
07/24/2002EP1225172A1 Polyorthoester and curable composition containing the same
07/24/2002EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
07/24/2002EP0760809B1 Application of omega-hydrofluoroalkyl ethers
07/24/2002CN1359751A Catalyst for removing dioxide and preparing method thereof
07/24/2002CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/17/2002CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
07/16/2002US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds
07/11/2002WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
07/11/2002US20020091242 Acid-sensitive compounds, their preparation and uses
07/11/2002US20020091152 Medicament for treatment of irritable bowel syndrome
07/10/2002EP1220828A1 Process for producing a purified lactic acid solution
07/10/2002EP0784617B1 Substituted diphenyl oxazolines
07/10/2002CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
07/09/2002US6417181 Viricides formed by catalytic hydrogenation
07/04/2002WO2002032373A3 Estrogen receptor modulators
07/04/2002WO2002020528A3 Fluorinated and alkylated alditol derivatives and polyolefin articles containing same
07/04/2002US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
07/04/2002US20020084446 Hyperpolarizable organic chromophores
07/03/2002EP1219617A1 Process for the preparation of cyclic lactic acid oligomers
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002EP0915837B1 Glyoxylic acid derivatives
07/03/2002EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines
07/03/2002CN1357020A Catalyst compsn. and use thereof
07/03/2002CN1356977A Glucagon antagonists/inverse agonists
06/2002
06/27/2002WO2002024613A3 Resorcinol derivatives
06/27/2002WO2002018323A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002WO2001081276A3 Method for producing ketal and/or acetal
06/27/2002US20020083492 Basidiomycete peroxidase gene-transferred plant and a method for decomposing and removing hazardous chemicals using the same
06/27/2002US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins
06/26/2002EP1105383A4 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
06/25/2002US6410600 Azine used as fungicides
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/20/2002WO2002048085A1 Process for producing product of decomposition of fluorinated ester compound
06/20/2002WO2002048081A1 Liquid crystalline compounds
06/20/2002WO2002048073A1 Method for producing compounds having a cf2o bridge
06/19/2002EP1214971A2 Catalyst for removing dioxin and preparation method thereof
06/18/2002US6407247 Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
06/18/2002US6407100 Fungicidal aromatic oximes
06/13/2002WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002WO2002004404A3 7,8 and 9-substituted tetracycline compounds
06/13/2002US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
06/13/2002US20020070127 Catalyst reactor for processing hazardous gas using non-thermal plasma and dielectric heat and method threreof
06/13/2002DE10061790A1 Flüssigkristalline Verbindungen Liquid-crystalline compounds
06/13/2002DE10041671C1 Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung Benzodiazepines process for the preparation of imidazo [1,2-c] [2,3] oxazole and phenylacetic acid esters and derivatives, as intermediates in the preparation thereof
06/13/2002CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002CA2431045A1 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002EP0916639B1 Liquid crystal compounds, liquid crystal compositions containing the compounds, and liquid crystal display devices made by using the compositions
06/12/2002EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/12/2002CN1353682A Treatment of composition comprising trimetlylohalkane bis-monolinear formal
06/06/2002WO2002044132A1 A process for the preparation of iopamidol and the new intermediates therein
06/06/2002US20020066888 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002CA2067929C Piperazine derivatives
05/2002
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/30/2002US20020065192 Productivity catalysts and microstructure control
05/29/2002DE10055940A1 Neue Indanylidenverbindungen New indanylidene
05/28/2002US6395367 Electroconductivity
05/23/2002WO2002040446A1 Glucagon antagonist/inverse agonist
05/23/2002WO2002040445A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002040444A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
05/23/2002WO2001083571A3 Catalysts containing n-pyrrolyl substituted nitrogen donors
05/23/2002WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives
05/23/2002WO2001042179A9 Compounds which mimic the chemical and biological properties of discodermolide
05/23/2002US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
05/22/2002EP1206467A1 N-heterocyclic derivatives as nos inhibitors
05/22/2002EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
05/22/2002CN1350523A Indoline derivatives as progesterohe antagonists
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
05/22/2002CN1085205C Bicyclic amino acids
05/21/2002US6391907 Anticancer agents; contraceptives
05/21/2002CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same
05/16/2002WO2002038537A1 Novel indanylidene compounds
05/16/2002US20020058768 For use in addition polymerization of olefins
05/16/2002US20020056827 Piezoelectric element and process for production thereof
05/16/2002CA2428322A1 Novel indanylidene compounds
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 103